A new extended-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients

This publication has 23 references indexed in Scilit:

• Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia
  Metabolism, 1998
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover
  Atherosclerosis, 1993
• Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?
  Metabolism, 1992
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• The effects of nicotinic acid treatment on high density lipoprotein particle size subclass levels in hyperlipidaemic subjects
  Atherosclerosis, 1990
• Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio
  The American Journal of Cardiology, 1989
• Nicotinic Acid-Induced Fulminant Hepatic Failure
  Journal of Clinical Gastroenterology, 1987
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
  Metabolism, 1985